'Iu ml hcv rna' diaporamas de présentation

TURQUOISE-I: SAFETY AND EFFICACY OF ABT-450/R/OMBITASVIR, DASABUVIR, AND RIBAVIRIN IN PATIENTS CO-INFECTED WITH HEPATITIS C AND HIV-1. Mark S. Sulkowski , Joseph J. Eron, David Wyles, Roger Trinh, Jay Lalezari, Jihad Slim, Joseph Gathe, Peter J. Ruane, Chia Wang, Richard Elion,

363 views • 18 slides

STARTVerso 4: High rates of early virologic response in HCV genotype 1/HIV-co-infected patients treated with faldaprevir plus pegIFN and RBV.

244 views • 14 slides

5 th Paris Hepatitis Congress Workshop 30/1/2012 Managing complications of DAAs : Case 1

5 th Paris Hepatitis Congress Workshop 30/1/2012 Managing complications of DAAs : Case 1. Dr Samuel S. Lee University of Calgary. Case 1. 51 year old Caucasian man HCV discovered 2009 on routine examination Remote history of injection drug use age 19 No symptoms

253 views • 13 slides